InspireMD (NSPR) FCF Margin Growth (3y) (2013 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 38.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 30.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 943.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 96.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -2,196.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -20.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 2,679.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -461.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 417.00 |
| 10 | InspireMD | 64.01 Mn | 9.80 Mn | 1.18 Mn | 1,126.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1,126.00 |
| Sep 30, 2025 | 1,725.00 |
| Jun 30, 2025 | -29,049.00 |
| Mar 31, 2025 | -24,592.00 |
| Dec 31, 2024 | -14,432.00 |
| Sep 30, 2024 | 6,304.00 |
| Jun 30, 2024 | -2,894.00 |
| Mar 31, 2024 | 1,647.00 |
| Dec 31, 2023 | 118,224.00 |
| Sep 30, 2023 | 4,461.00 |
| Jun 30, 2023 | 26,944.00 |
| Mar 31, 2023 | -16,427.00 |
| Dec 31, 2022 | -16,064.00 |
| Sep 30, 2022 | -16,735.00 |
| Jun 30, 2022 | 1,069.00 |
| Mar 31, 2022 | 50,308.00 |
| Dec 31, 2021 | 587.00 |
| Sep 30, 2021 | -16,311.00 |
| Jun 30, 2021 | -2,731.00 |
| Mar 31, 2021 | -18,765.00 |
| Dec 31, 2020 | -121,630.00 |
| Sep 30, 2020 | -2,078.00 |
| Jun 30, 2020 | -22,365.00 |
| Mar 31, 2020 | 28,394.00 |
| Dec 31, 2019 | 43,532.00 |
| Sep 30, 2019 | 42,538.00 |
| Jun 30, 2019 | -7,423.00 |
| Mar 31, 2019 | -52,440.00 |
| Dec 31, 2018 | 20,658.00 |
| Jun 30, 2018 | 13,229.00 |
| Mar 31, 2017 | -26,045.00 |
| Sep 30, 2016 | -41,451.00 |
| Jun 30, 2016 | 16,070.00 |
| Mar 31, 2016 | -14,315.00 |
| Dec 31, 2015 | -17,154.00 |
| Mar 31, 2014 | -22,807.00 |
| Sep 30, 2013 | -13,863.00 |